Purpose To investigate potential indicators of in vitro fertilization (IVF) treatment outcome for female infertility patients aged C 40 years based on the clinical course. Methods We retrospectively examined results of 111 female infertility patients aged C 40 years undergoing IVF treatment. We investigated the relationship between treatment cycle cancellation and the final outcome of IVF treatment in female infertility patients aged C 40 years.
Introduction
Many female infertility patients have conceived and achieved live births with assisted reproductive technology (ART); however, the outcomes of ART in patients aged C 40 years are still unfavorable and the development of more effective treatment for these women is desired. In Japan in recent years, treatment cycles for female infertility patients aged C 40 years are markedly increasing; it is not uncommon for female infertility patients to continue infertility treatment until the menopause. Some nations permit oocyte donation through legislation addressing assisted reproduction. In Israel, for example, national health insurance covers most infertility treatments, including in vitro fertilization and embryo transfer (IVF-ET), for the first two children. The age limit for performing IVF-ET with an infertile woman's own oocytes is 45 years [1] .
In Japan, oocyte donation is not permitted according to the guidelines of the Japan Society of Obstetrics and Gynecology. Therefore, Japanese female infertility patients can only receive IVF-ET treatment using their own oocytes. Furthermore, Japanese women are traditionally expected to bear children [2, 3] with some Japanese infertility patients continuing to undergo infertility treatment because of parental pressure rather than their own desire [3] . Such social and traditional backgrounds concerning reproduction produce considerable stress for Japanese female infertility patients aged C 40 years. The outcome of infertility treatment should be explained to such patients beforehand. With regard to factors influencing the outcome of IVF-ET, Tsafrir et al. [1] noted in their retrospective analysis of 1,217 IVF cycles in women aged C 40 years that none of 10 patients treated after 45 years of age delivered successfully. Klimpstein et al. [4] reported that the highest cycle day 3 follicle stimulating hormone (CD3 FSH) level in a 43-year-old woman achieving pregnancy was 18.0 mIU/mL and the highest CD3 FSH in a 40-year-old woman delivering a live child was 15.4 mIU/mL in their review of 2,705 cycles. Age and CD3 FSH level may thus provide useful indicators for treatment cut-off; however, an indicator for treatment cut-off based on the clinical course would be a more useful and more readily identified parameter for Japanese female infertility patients aged C 40 years. The purpose of the present study was to summarize our experience regarding infertility treatment for these women and to determine an indicator for treatment cut-off based on the clinical course.
Materials and methods
The study included patient data from all infertile women aged C 40 years at the time of IVF-ET treatment from 2004 to 2008 at Jikei University Hospital, Fuji Central Hospital and Kusuhara Ladies Clinic in Japan. A total of 111 women underwent 364 initiated cycles. Age distribution at the time of IVF-ET treatment is presented in Table 1 . The protocol for ovarian stimulation was determined based on ovarian reserves, estimated by either CD3 FSH or previous ovarian response. The long, desensitization protocol using gonadotropin-releasing hormone (GnRH) agonist was conducted in patients estimated to have good ovarian reserve. The short protocol using a GnRH antagonist was conducted in patients estimated to have poor ovarian reserve. The clomiphene citrate or natural protocol was applied to the women in whom zero or one follicle developed in a previous long protocol, short protocol, or GnRH antagonist protocol.
Conventional IVF or intracytoplasmic sperm injection (ICSI) was performed depending on sperm condition or fertilization results in previous treatment cycles. Embryo transfer was performed on day 3. Cryopreserved-thawed embryo transfer was performed in cycles with a high risk of ovarian hyperstimulation syndrome or suboptimal endometrium.
Women were tested for urinary human chronic gonadotropin (HCG) about 14 days after embryo transfer. If this pregnancy test was positive, a clinical pregnancy was diagnosed based on the presence of an intrauterine gestational sac on transvaginal ultrasound. When pregnancy was diagnosed, luteal support was continued until 8 weeks' gestation.
Initial analysis included the results of all 364 initiated treatment cycles regarding rates of pregnancy, spontaneous abortion, and cancellation. Subsequent analyses comprised comparisons of: (1) outcome by age; (2) outcome by number of treatment cycles; and (3) the relationship of outcomes with cancellation cycles and patient background to cancellation cycles, respectively.
Statistical analysis
Student's t test was applied for continuous variables, and the chi-squared (v 2 ) test was used for binary variables. A P value \0.05 was considered statistically significant.
Results
Demographic data (Table 2) During the study period, 364 treatment cycles including oocyte pick-up cancellation cycles and embryo transfer cancellation cycles were initiated in 111 female infertility patients aged C 40 years. A total of 42 (11.5%) oocyte pick-up cycles were canceled primarily because of poor ovarian response, while 120 (33.0%) embryo transfer cycles were canceled because of non-retrieval of an oocyte, no fertilized ovum, or nonviable embryo quality. A total of 44 pregnancies were achieved. Overall pregnancy rate per initiated treatment cycles was 12.1%. Pregnancy rate per treatment cycle, excluding oocyte pick-up or embryo transfer cancellation, was 21.8%; 24 of 44 cycles in which a pregnancy was achieved terminated in a spontaneous abortion (54.5%). The cause of infertility was examined in Reprod Med Biol all 111 patients. As shown in Fig. 1 , the majority of cases were determined to be unexplained infertility (55%). The clomiphene citrate protocol was most frequently used in controlled ovarian hyperstimulation ( Fig. 2 ). There were no significant differences in the pregnancy rates between the five protocols.
Outcome of IVF treatment cycles according to age (Table 3) Pregnancy rates averaged 12.9% between 40 and 44 years of age but dropped to 0% at C 45 years. Rates of spontaneous abortion and cancellations for oocyte pick-up and embryo transfer increased considerably at C 44 years.
Outcome of IVF treatment cycles according to cycle number (Table 4) No patients conceived after C 10 treatment cycles. Spontaneous abortion rates increased considerably after six treatment cycles. Combined cancellation rates for oocyte pick-up and embryo transfer increased to [ 40% at C 4 treatment cycles.
Relationship between outcome of IVF treatment cycles and cancellation of treatment cycle Treatment cycles of patients aged C 40 are often cancelled at oocyte pick-up or embryo transfer; such cancellations indicate an unfavorable outcome. We examined the relationship between cancellation of oocyte pick-up or embryo transfer and outcome of ART in the present patients. Initially, patients were classified into two groups according to whether they experienced oocyte pick-up cancellation. A total of 18 patients (141 cycles) who had oocyte pick-up canceled, primarily because of poor follicular response, were assigned to Group A. Group B comprised 93 patients (223 cycles) without oocyte pick-up cancellation. Clinical background (present age, age at marriage, age at onset of infertility treatment, duration of infertility, duration of infertility treatment prior to IVF, and cause of infertility) and ovarian reserves (CD3 FSH, human menopausal gonadotropin (hMG) ampoules (i.e., 75 IU), and number of oocytes retrieved) were compared. No significant differences were observed between the two groups with regard to clinical background (Table 5) ; however, Group A had significantly higher CD3 FSH and significantly lower oocyte retrieval (Table 6 ). These results indicate that the No. of oocyte pick-up cancellation cycles 42
Cancellation rate of oocyte pick-up per initiated cycle (%) 11.5
No. of oocyte embryo transfer cancellation cycles 120
Cancellation rate of embryo transfer per initiated cycles (%) 33.0 Fig. 1 The majority of cases were determined to be unexplained infertility (55%) Fig. 2 The clomiphene citrate protocol was most frequently used in controlled ovarian hyperstimulation Subsequently, patients were classified into two groups according to whether they experienced embryo transfer cancellation (Table 6 ). A total of 57 patients (261 cycles) experiencing embryo transfer cancellation, mainly because of fertilization failure or lack of viable embryo, were assigned to Group C. Group D comprised 54 patients (103 cycles) without embryo transfer cancellation. The clinical backgrounds (present age, age at marriage, age at onset of infertility treatment, infertility duration, duration between onset of infertility treatment and onset of ART, and cause of infertility) and ovarian reserves (CD3 FSH, hMG ampoules, and number of oocytes retrieved) were compared. No significant differences were observed between the two groups with regard to clinical background; however, Group C had significantly higher CD3 FSH and hMG ampoules and significantly lower oocyte retrieval. These results revealed that the ovarian reserves of Group C were significantly lower than that of Group D. There was no significant difference between Groups C and D in the cumulative pregnancy rate per patient (40.4% vs. 38.9%) or in the pregnancy rate per treatment cycles in which embryo transfer was performed (22.8% vs. 20.8%); however, the spontaneous abortion rate of Group C (73.9%) was significantly higher than that of Group D (33.3%). 
Discussion
In 2007, approximately 600 IVF institutions were registered with the Japan Society of Obstetrics and Gynecology and 160,000 treatment cycles (including conventional IVF fresh embryo transfer and ICSI, fresh embryo transfer or cryopreserved-thawed embryo transfer) were performed in Japan. The present status of ART reflects the high desirability of pregnancy in Japan which is due not only to the wishes of the patient but also family pressure as many Japanese still believe that motherhood is a wife's duty [2, 3] . Perhaps due to the historical background, the continuation of infertility treatment by Japanese female infertility patients may represent a sense of social duty as well as personal desire. Oocyte donation is not permitted in Japan so infertile women must undergo treatment with their own oocytes; some women continue treatment until the menopause. In the present study, we summarized the treatment of female infertile patients aged C 40 years and examined individual data to determine a cut-off point for infertility treatment.
Aggregate rates of pregnancy and delivery per initiated treatment cycle were 12.1% and 5.5%, respectively. In infertile women aged C 40 years, Klipstein et al. [4] reported a pregnancy rate per initiated treatment cycle of 17.3% in 2,705 initiated IVF treatment cycles, Las et al. [5] described a rate of 11.3% in 1,087 cycles, and Tsafrir et al. [1] described a rate of 7.3% in 1,217 cycles; all results were \ 20%.
In the present study no pregnancies were achieved in women aged C 45 at the time of treatment cycle onset. Klipstein et al. [4] reported that no pregnancies were achieved in women aged C 46 and they concluded that pregnancies at C 44 years of age are rare. Lass et al. [5] reported no pregnancies achieved in women aged C 45 years at the time of treatment cycle onset, while Tsafrir et al. [1] recommended that women aged C 44 years should not undergo IVF. The cut-off age for IVF treatment appears to be approximately 45 years.
In the present study, the highest treatment cycle in which a pregnancy was achieved was cycle 9; however, this pregnancy miscarried at 7 weeks' gestation. The highest treatment cycle in which an infant was delivered was cycle 8. Martin-Johnston et al. [6] reported that the likelihood of a successful outcome declines with each additional treatment cycle. They concluded that the most notable decrease in clinical pregnancy rates occurred after the third treatment cycle, and patients who fail to conceive after three IVF cycles should be counseled to consider other options. The correlation between treatment cycle number and treatment outcome should be evaluated further in Japan and the cut-off age should be determined excluding treatment options such as oocyte donation.
The percentage of initiated cycles for patients aged C 45 years at treatment cycle onset was 9.9% (36 cycles). Furthermore, the percentage of non-cancelled cycles after 10 treatment cycles was 18.4% (67 cycles). These findings indicate that parameters for treatment cutoff are not well established.
Treatment cancellations for oocyte pick-up or embryo transfer often occur in women over 40 years of age undergoing IVF procedures. In the present study, 42 (11.5%) oocyte pick-up cycles and 120 (33.0%) embryo transfer cycles were canceled. Only a few studies have examined the correlation between cancellation of IVF treatment cycle and outcome. Using logistic regression analysis, Peñarrubia et al. [7] demonstrated that the history of an IVF/ICSI cancelled cycle due to poor follicular response in a standard Lower ovarian reserves correlated with a poorer outcome for IVF treatment in women aged C 40 years. Moreover, patients who experience embryo transfer cancellation have a higher spontaneous abortion rate if they achieve a pregnancy. In addition, few women who experience oocyte pick-up cancellation achieve a pregnancy, and fewer deliver a viable infant.
Klipstein et al. [4] reported that CD3 FSH values correlate with pregnancy, live birth, and pregnancy loss rates. Additionally, in their review of 2,705 cycles, they reported that the highest CD3 FSH level in a woman achieving a pregnancy was 18.0 mIU/mL, and that the highest CD3 FSH in a woman delivering a live child was 15.4 mIU/mL. The present study found that the highest CD3 FSH level in a woman achieving a pregnancy was 22.2 mIU/mL, and that the highest level in a woman delivering a live child was 17.6 mIU/mL. Therefore, IVF treatment may not be efficacious for women C 40 years whose CD3 FSH is [ 20 mIU/mL. As CD3 FSH values fluctuate in each cycle, anti-Müllerian hormone may be a useful marker of ovarian reserves in women C 40 years; thus, it would be of value regarding the decision of infertility treatment cut-off.
We evaluated potential indicators for treatment cut-off for women C 40 years: age, number of treatment cycles, and cancellation of treatment cycle. The present findings suggest that cancellation of treatment cycles is as useful an indicator as age or the number of treatment cycle. However, further research is necessary with larger patient populations encompassing more parameters. Once established, realistic cut-off criteria for infertility treatment should be disseminated to Japanese society to help prevent social and family pressure. Moreover, consideration should be given to how, when and by whom counseling should be given regarding ending infertility treatment.
